New diabetes clinical trial: Fibrosis Lessens After Metabolic Surgery

Published on: April 18, 2024 at 11:00PM
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis (MASH); Liver Fibrosis; Obesity
Interventions: Procedure: Metabolic surgery; Drug: Incretin-Based Therapy
Sponsors: Ali Aminian
Not yet recruiting
https://ift.tt/FXbHVh6